Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Sandra Adele (cohort 2019-2020) co-authored this paper on the efficacy of the Oxford Astra-Zeneca vaccine for the 40 million people globally living with HIV. This study aimed to assess the vaccine’s ability to stimulate an immune response on those who have their immunity compromised.

The study was conducted in November 2020. 54 male participants, diagnosed with HIV, were eligible for the study.

They received two doses of Oxford Astra-Zeneca vaccine. 

The study found the vaccine to be effective and safe for those living with HIV.

Read the full study on the Science Direct's website.